Skip to main content
. 2022 Jan 25;11(3):414. doi: 10.3390/cells11030414

Figure 3.

Figure 3

Receiver operating curve (ROC) of sST2, NT-pro-BNP, and Troponin T for the detection of (A) NYHA functional class III/IV and (B) the presence of adverse cardiovascular events (cardiovascular death, malignant arrhythmias, and/or ICD implantation and hospitalization due to heart failure symptoms) at 12 months follow-up in patients with ICM.